# Review Scorecard — Riley's_Office

- Project: `C:\Users\omino\.openclaw\workspace\projects\Riley's_Office`
- Run ID: `riley-office-review-wave-2`
- Reviewer role: `reviewer`
- Validation Class: `V2`
- Review date: `2026-03-28`
- Final verdict: **PASS**
- Final score: **99/100**

## Reviewer decision
The refreshed package meets the workspace quality bar. The current claims are aligned with fresh proof: `package.json` shows `next@15.5.14`, `QA-REPORT.md` documents a fresh wave-2 QA pass, and the latest evidence set shows successful install, audit, typecheck, and production build with all recorded exit codes at `0`.

The prior reviewer concern about vulnerable `next@15.2.4` is no longer present in the reviewed state. I am applying a small deduction only for missing project-local context files (`PROJECT.md` and `BRAND.md`), which are acknowledged consistently across the package and do not invalidate readiness.

## Criterion-level scoring
| Criterion | Score | Notes |
|---|---:|---|
| Artifact completeness vs required review scope | 20/20 | Required review artifact, QA report, README, implementation summary, and fresh evidence set are present. |
| Claims matched by proof | 20/20 | README, implementation summary, and QA report all match the fresh wave-2 evidence. |
| Validation freshness and reliability | 20/20 | Latest QA evidence is dated `2026-03-28` and shows install, audit, typecheck, and build all passing. |
| Runtime/build readiness | 20/20 | Build log shows successful Next.js `15.5.14` production build and expected routes generated. |
| Documentation/context completeness | 19/20 | Local startup/readiness docs are solid; minor deduction because `PROJECT.md` and `BRAND.md` are absent at project root. |
| **Total** | **99/100** | **Pass threshold exceeded.** |

## Evidence reviewed
- `C:\Users\omino\.openclaw\workspace\projects\Riley's_Office\QA-REPORT.md`
- `C:\Users\omino\.openclaw\workspace\projects\Riley's_Office\README.md`
- `C:\Users\omino\.openclaw\workspace\projects\Riley's_Office\IMPLEMENTATION-SUMMARY.md`
- `C:\Users\omino\.openclaw\workspace\projects\Riley's_Office\package.json`
- `C:\Users\omino\.openclaw\workspace\projects\Riley's_Office\evidence\qa-status-2026-03-28-wave2.json`
- `C:\Users\omino\.openclaw\workspace\projects\Riley's_Office\evidence\npm-audit-omit-dev-2026-03-28-wave2.json`
- `C:\Users\omino\.openclaw\workspace\projects\Riley's_Office\evidence\typecheck-2026-03-28-wave2.log`
- `C:\Users\omino\.openclaw\workspace\projects\Riley's_Office\evidence\build-2026-03-28-wave2.log`
- `C:\Users\omino\.openclaw\workspace\projects\Riley's_Office\evidence\npm-install-2026-03-28-wave2.log`

## Findings
### Confirmed strengths
- Fresh QA pass is internally consistent and tied to exact wave-2 evidence.
- `npm audit --omit=dev` reports `0` vulnerabilities in the current reviewed state.
- `npm run typecheck` passes with no TypeScript errors.
- `npm run build` passes on `Next.js 15.5.14` and generates `/`, `/activity`, `/agents/[agentid]`, `/inbox`, and `/projects/[projectid]`.
- README startup instructions and implementation summary align with the validated mock-first local-readiness scope.

### Non-blocking gap
- `PROJECT.md` and `BRAND.md` are not present at the project root. This is documented consistently and does not block acceptance.

## Final acceptance verdict against contract
| Acceptance test | Result | Basis |
|---|---|---|
| Review the latest QA/report/build evidence | PASS | Reviewed latest wave-2 QA report plus wave-2 evidence files. |
| Confirm claims align with proof | PASS | Documentation claims match the passing audit/typecheck/build evidence and patched dependency state. |
| Produce final score out of 100 | PASS | This scorecard records `99/100`. |
| Pass the package if it meets the quality bar | PASS | Package clears the workspace threshold and is approved. |
